Ethnic, socio-demographic and socio-economic differences in surgical treatment of breast cancer in New Zealand

ANZ Journal of Surgery

Volumn 87, Issue 7-8, 2017, Pages E32-E39

  Seneviratne, Sanjeewa ^a   Scott, Nina ^b   Lawrenson, Ross ^a   Campbell, Ian ^a,b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

breast cancer; breast conserving surgery; breast reconstruction; ethnicity; inequity; mastectomy

Indexed keywords

ADULT; AGED; BREAST RECONSTRUCTION; BREAST TUMOR; CAUCASIAN; COMPARATIVE STUDY; DEMOGRAPHY; ETHNIC GROUP; FEMALE; HUMAN; MASTECTOMY; MIDDLE AGED; NEW ZEALAND; PATHOLOGY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SOCIOECONOMICS; STANDARDS; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; DEMOGRAPHY; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MAMMAPLASTY; MASTECTOMY; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SOCIOECONOMIC FACTORS;

EID: 84923584333     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/ans.13011     Document Type: Article

References (36)

1. NIH Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991; 265: 391–395.
2. Krag DN, Anderson SJ, Julian TB et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010; 11: 927–933.
3. (NBOCC) NBaOCC. Recommendations for Use of Sentinel Node Biopsy in Early (Operable) Breast Cancer. New South Wales, Australia: Cancer Australia, 2011.
4. Lyman GH, Giuliano AE, Somerfield MR et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J. Clin. Oncol. 2005; 23: 7703–7720.
5. Nesvold I-L, Dahl AA, Løkkevik E, Marit Mengshoel A, Fosså SD. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy. Acta Oncol. (Madr) 2008; 47: 835–842.
6. Burak WE Jr, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am. J. Surg. 2002; 183: 23–27.
7. Albornoz CR, Bach PB, Mehrara BJ et al. A paradigm shift in US Breast reconstruction: increasing implant rates. Plast. Reconstr. Surg. 2013; 131: 15–23.
8. Nold RJ, Beamer RL, Helmer SD, McBoyle MF. Factors influencing a woman's choice to undergo breast-conserving surgery versus modified radical mastectomy. Am. J. Surg. 2000; 180: 413–418.
9. Morrow M, White J, Moughan J et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J. Clin. Oncol. 2001; 19: 2254–2262.
10. Brennan M, Spillane A. Uptake and predictors of post-mastectomy reconstruction in women with breast malignancy – systematic review. Eur. J. Surg. Oncol. 2013; 39: 527–541.
11. Roder D, Zorbas H, Kollias J et al. Factors predictive of immediate breast reconstruction following mastectomy for invasive breast cancer in Australia. Breast 2013; 22: 1220–1225.
12. Hislop TG, Olivotto IA, Coldman AJ et al. Variations in breast conservation surgery for women with axillary lymph node negative breast cancer in British Columbia. Can. J. Public Health 1996; 87: 390–394.
13. Jeevan R, Cromwell DA, Browne JP et al. Regional variation in use of immediate breast reconstruction after mastectomy for breast cancer in England. Eur. J. Surg. Oncol. 2010; 36: 750–755.
14. Tseng JF, Kronowitz SJ, Sun CC et al. The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 2004; 101: 1514–1523.
15. Stevens W, Stevens G, Kolbe J, Cox B. Ethnic differences in the management of lung cancer in New Zealand. J. Thorac. Oncol. 2008; 3: 237–244.
16. Hill S, Sarfati D, Blakely T et al. Ethnicity and management of colon cancer in New Zealand: do indigenous patients get a worse deal? Cancer 2010; 116: 3205–3214.
17. Seneviratne S, Campbell I, Scott N, Coles C, Lawrenson R. Treatment delay for Māori women with breast cancer in New Zealand. Ethn. Health 2015; 20: 178–193.
18. Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Round G, Lawrenson R. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study. BMC Cancer 2014; 14: 839.
19. Page A, Taylor R. BreastScreen Aotearoa: independent monitoring report – treatment of women with BSA detected cancers (women screened July 2005–June 2007). Wellington, 2009.
20. Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R. Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer. Cancer Epidemiol. 2014; 38: 638–644.
21. AJCC Cancer Staging Manual, 7th edn. New York: Springer-Verlag, 2010.
22. Salmond C, Crampton P, Atkinson J. NZDep2006: Index of Deprivation. Department of Public Health, University of Otago. Wellington: Ministry of Health, 2007.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987; 40: 373–383.
24. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp., 2013.
25. Caldon L, Collins K, Wilde D et al. Why do hospital mastectomy rates vary & quest: differences in the decision-making experiences of women with breast cancer. Br. J. Cancer 2011; 104: 1551–1557.
26. Gaudette LA, Gao R-N, Spence A, Shi F, Johansen H, Olivotto IA. Declining use of mastectomy for invasive breast cancer in Canada, 1981–2000. Can. J. Public Health 2004; 95: 336–340.
27. New Zealand Guidelines Group. Management of Early Breast Cancer – Evidence Based Best Practice Guideline. Wellington: Ministry of Health, 2009.
28. Mastaglia B, Kristjanson LJ. Factors influencing women's decisions for choice of surgery for Stage I and Stage II breast cancer in Western Australia. J. Adv. Nurs. 2001; 35: 836–847.
29. Fallowfield LJ, Baum M, Maguire GP. Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br. Med. J. (Clin. Res. Ed) 1986; 293: 1331–1334.
30. Benedict S, Cole DJ, Baron L, Baron P. Factors influencing choice between mastectomy and lumpectomy for women in the Carolinas. J. Surg. Oncol. 2001; 76: 6–12.
31. Pham JT, Allen LJ, Gomez SL. Why do Asian-American women have lower rates of breast conserving surgery: results of a survey regarding physician perceptions. BMC Public Health 2009; 9: 246.
32. Minicozzi P, Cirilli C, Federico M et al. Differences in stage and treatment of breast cancer across Italy point to inequalities in access to and availability of proper care. Tumori 2012; 98: 204–209.
33. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch. Intern. Med. 2003; 163: 49–56.
34. Salmond CE, Crampton P. Development of New Zealand's deprivation index (NZDep) and its uptake as a national policy tool. Can. J. Public Health 2012; 103 (8 Suppl. 2): S7–11.
35. Morrow M, Mujahid M, Lantz PM et al. Correlates of breast reconstruction. Cancer 2005; 104: 2340–2346.
36. Spillane A, Brennan M. Accuracy of sentinel lymph node biopsy in large and multifocal/multicentric breast carcinoma – a systematic review. Eur. J. Surg. Oncol. 2011; 37: 371–385.